Published in Medical Letter on the CDC and FDA, August 6th, 2000
The findings were reported at the American Society of Microbiology International Conference on Emerging Infectious Diseases, held in Atlanta, Georgia, July 16-19, 2000.
"Penicillin-resistant organisms often produce beta-lactamase, an enzyme that blocks the effectiveness of penicillin and cephalosporin antibiotics," explained H. Michael Shepard, PhD, NewBiotics. "NB2001 releases a highly potent bacterial toxin that is triggered by this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.